(Q53234366)

12 May 2018

title

Effect of intravenous pamidronate therapy on everyday activities in children with osteogenesis imperfecta. (English)

1 reference

12 May 2018

main subject

osteogenesis imperfecta

0 references

author name string

Kristina Löwing

1

1 reference

12 May 2018

Eva Aström

2

1 reference

12 May 2018

Katarina Allbrink Oscarsson

3

1 reference

12 May 2018

Stefan Söderhäll

4

1 reference

12 May 2018

Ann-Christin Eliasson

5

1 reference

12 May 2018

language of work or name

English

0 references

publication date

18 June 2007

1 reference

12 May 2018

published in

Acta Paediatrica

1 reference

12 May 2018

volume

96

1 reference

12 May 2018

issue

8

1 reference

12 May 2018

page(s)

1180-1183

1 reference

12 May 2018

cites work

Osteogenesis imperfecta

1 reference

https://api.crossref.org/works/10.1111%2FJ.1651-2227.2007.00390.X

Two-year clinical trial of oral alendronate versus intravenous pamidronate in children with osteogenesis imperfecta

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1651-2227.2007.00390.X

Cyclic administration of pamidronate in children with severe osteogenesis imperfecta

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1651-2227.2007.00390.X

Beneficial effect of long term intravenous bisphosphonate treatment of osteogenesis imperfecta

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1651-2227.2007.00390.X

Impact of alendronate on quality of life in children with osteogenesis imperfecta

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1651-2227.2007.00390.X

Intravenous bisphosphonate therapy in children with osteogenesis imperfecta

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1651-2227.2007.00390.X

Bisphosphonate-induced osteopetrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1651-2227.2007.00390.X

Skeletal effects and functional outcome with olpadronate in children with osteogenesis imperfecta: a 2-year randomised placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1651-2227.2007.00390.X

Dual-energy X-ray absorptiometry in normal women: a cross-sectional study of 717 Finnish volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1651-2227.2007.00390.X

Pamidronate treatment of osteogenesis imperfecta--lack of correlation between clinical severity, age at onset of treatment, predicted collagen mutation and treatment response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1651-2227.2007.00390.X

Osteogenesis imperfecta in childhood: impairment and disability. A prospective study with 4-year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1651-2227.2007.00390.X

10.1111/J.1651-2227.2007.00390.X

21 January 2018

Identifiers

DOI

1 reference

12 May 2018

PubMed ID

17578486

1 reference

12 May 2018